COMPANY PROFILE

Stämm

Explore full profile

Stämm is downsizing a whole biotech plant into an all, pug-n-play desktop unit

San Francisco, United StatesFounded 2016Biotech & Life Sciences

Valuation $100–250M Last recorded · 2022

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Stämm

Stamm.bio is a biotechnology company focused on revolutionizing biomanufacturing by making it easy, scalable, and repeatable. Founded in 2016, the company operates in the biopharma industry and serves clients ranging from small biotech startups to large pharmaceutical companies. Stamm.bio's core product, the Bioprocessor, downsizes an entire biotech facility into a plug-and-play desktop unit using laminar flow technology. This innovation allows for continuous production and unidirectional flow, making bioprocesses more efficient and accessible. The company also leverages microfluidics and 3D printing to create a zero marginal cost of innovation in biotech. Stamm.bio generates revenue through sales of its Bioprocessor units, partnerships, and collaborations with other biotech firms. The business model focuses on decentralizing bioprocesses and democratizing access to biotechnology products, enabling partners to concentrate on groundbreaking discoveries.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: San Francisco, United States
Employees: 142
Open positions: 7
Dealroom signal: 59.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Arts & Culture, Biotech and Pharma, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BEquity / VC	Apr 2023	$0	—	Indie Bio · SOSV	—
SERIES A✓Equity / VC	Feb 2022	$17M	$68M	Draper Associates · Teramips Technologies · Draper Cygnus · GRIDX	↗

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Stämm website traffic

Latest recorded traffic for Stämm is 4.2K monthly website visits, up 740% over the last three months. Stämm's team declined 17.4% over the past year.

Latest monthly visits4.2K 3-month web change+740% 1-year team growth-17.4%

Monthly website visitsJun 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Microfluidics SpecialistBuenos Aires, Argentina, South America, Americas · Other · Aug 28, 2026 IT Support & Infrastructure SpecialistBuenos Aires, Argentina, South America, Americas · CSM & Support · Aug 28, 2026 Coating SpecialistBuenos Aires, Argentina, South America, Americas · Other · Aug 28, 2026 Post processing ChemistBuenos Aires, Argentina, South America, Americas · Other · Aug 28, 2026 Purchasing SpecialistBuenos Aires, Argentina, South America, Americas · Accounting · Aug 28, 2026 Software EngineerBuenos Aires, Argentina, South America, Americas · Backend Development · Aug 26, 2026 Bio-Analytics SpecialistGreater Buenos Aires · Business Intelligence · Aug 4, 2026

7 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SPSurface PharmaceuticalsInnovative ophthalmic solutions enhancing eye care with advanced therapeutics	California City, United States	Operational	—	$47M	$84M
XPXoc PharmaceuticalsA biopharmaceutical company based in Los Gatos, Calif	Los Gatos, United States	Operational
PHPharmaNetUSAPharmaNetUSA Inc with breakthrough innovations in drug testing and specialized Medical Clinics	Boca Raton, United States	Closed
ONOncobiologicsPrivately-held biopharmaceutical company	Cranbury Township, United States	Operational
PPPharmawizard - PWReference guideline for the informed use of drug - Subsidiary @datawizard	Rome, Italy	Operational
VIVigene Biosciences Inc.Vigene Biosciences - Excellence in Gene Delivery	Rockville, United States	Acquired
PSPhi Life SciencesA Molecular Diagnostic and Laboratory Service company	Charleston, United States	Operational
PHPhenoxDedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of neurovascular diseases	Bochum, Germany	Acquired